China Plans To Establish National FDA Information Sharing System
This article was originally published in PharmAsia News
In China's 12th Five-Year Plan period, the country aims to establish drug testing institutes in most of its cities and counties, a national pharmaceutical information management network and a drug quality information sharing platform for all of its regional FDAs, aiming to achieve comprehensive digital pharmaceutical testing and management, China's State FDA Commissioner Shao Mingli said at a recent national conference on drug and medical device standards
You may also be interested in...
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.
FDA's recommendation that COVID-19 vaccine sponsors conduct two months of median follow-up to support an emergency use authorization may not be long enough, some experts say in what can be viewed as validation for agency's position in battle with White House.